GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology

ASCO 2026 spotlights metabolic health in cancer care, as anti-obesity drugs show links to lower metastasis and survival gains, needing trials. https://www.cancernetwork.com/view/glp-1-receptor-agonists-and-cancer-renewed-momentum-for-metabo-oncology